Cargando…

Accelerated hyperfractionation plus temozolomide in glioblastoma

INTRODUCTION: Hyperfractionated (HFRT) or accelerated hyperfractionated radiotherapy (AHFRT) have been discussed as a potential treatment for glioblastoma based on a hypothesized reduction of late radiation injury and prevention of repopulation. HFRT and AHFRT have been examined extensively in the p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaul, David, Florange, Julian, Badakhshi, Harun, Grün, Arne, Ghadjar, Pirus, Exner, Sebastian, Budach, Volker
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4875722/ https://www.ncbi.nlm.nih.gov/pubmed/27209069 http://dx.doi.org/10.1186/s13014-016-0645-3

Ejemplares similares

Locally dose-escalated radiotherapy may improve intracranial local control and overall survival among patients with glioblastoma
por: Zschaeck, Sebastian, et al.
Publicado: (2018)

Are prognostic indices for brain metastases of melanoma still valid in the stereotactic era?
por: Badakhshi, Harun, et al.
Publicado: (2018)

Adjuvant radiotherapy improves progression-free survival in intracranial atypical meningioma
por: Hemmati, Saman Moritz, et al.
Publicado: (2019)

Prognostic indices in stereotactic radiotherapy of brain metastases of non-small cell lung cancer
por: Kaul, David, et al.
Publicado: (2015)

Accelerated hyperfractionated radiochemotherapy with temozolomide is equivalent to normofractionated radiochemotherapy in a retrospective analysis of patients with glioblastoma
por: Lewitzki, Victor, et al.
Publicado: (2019)

Impact of weight loss on survival after chemoradiation for locally advanced head and neck Cancer: secondary results of a randomized phase III trial (SAKK 10/94)
por: Ghadjar, Pirus, et al.
Publicado: (2015)

Outcome of Elderly Patients with Meningioma after Image-Guided Stereotactic Radiotherapy: A Study of 100 Cases
por: Kaul, David, et al.
Publicado: (2015)

Linac-based stereotactic radiotherapy and radiosurgery in patients with meningioma
por: Kaul, David, et al.
Publicado: (2014)

Intermediate-term outcome after PSMA-PET guided high-dose radiotherapy of recurrent high-risk prostate cancer patients
por: Zschaeck, Sebastian, et al.
Publicado: (2017)

Continuous, hyperfractionated, accelerated radiotherapy (CHART).
por: Dische, S., et al.
Publicado: (1989)

The impact of patient compliance with adjuvant radiotherapy: a comprehensive cohort study
por: Badakhshi, Harun, et al.
Publicado: (2013)

Modern radiation therapy and potential fertility preservation strategies in patients with cervical cancer undergoing chemoradiation
por: Ghadjar, Pirus, et al.
Publicado: (2015)

A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck
por: Budach, W, et al.
Publicado: (2006)

The impact of (18) F-FET PET-CT on target definition in image-guided stereotactic radiotherapy in patients with skull base lesions
por: Badakhshi, Harun, et al.
Publicado: (2014)

Risk adapted dose-intensified postoperative radiation therapy in prostate cancer patients using a simultaneous integrated boost technique applied with helical Tomotherapy
por: Beck, Marcus, et al.
Publicado: (2017)

Dose-escalated radiotherapy for unresectable or locally recurrent pancreatic cancer: Dose volume analysis, toxicity and outcome of 28 consecutive patients
por: Zschaeck, Sebastian, et al.
Publicado: (2017)

Regional hyperthermia combined with chemotherapy in paediatric, adolescent and young adult patients: current and future perspectives
por: Seifert, Georg, et al.
Publicado: (2016)

Definitive hyperfractionated, accelerated proton reirradiation for patients with pelvic malignancies
por: Moningi, Shalini, et al.
Publicado: (2019)

Role of Dose Intensification for Salvage Radiation Therapy after Radical Prostatectomy
por: Beck, Marcus, et al.
Publicado: (2016)

Reirradiation of High-Grade Gliomas: A Retrospective Analysis of 198 Patients Based on the Charité Data Set
por: Kaul, David, et al.
Publicado: (2020)

Hyperfractionated-Accelerated Reirradiation with Proton Therapy for Radiation-Associated Breast Angiosarcoma
por: Looi, Wen Shen, et al.
Publicado: (2022)

Results for local control and functional outcome after linac-based image-guided stereotactic radiosurgery in 190 patients with vestibular schwannoma
por: Badakhshi, Harun, et al.
Publicado: (2014)

Accelerated hyper-versus normofractionated radiochemotherapy with temozolomide in patients with glioblastoma: a multicenter retrospective analysis
por: Klement, Rainer J., et al.
Publicado: (2021)

Apatinib Plus Temozolomide: An Effective Salvage Treatment for Recurrent Glioblastoma
por: Ge, Jingjing, et al.
Publicado: (2021)

Regional hyperthermia of the abdomen, a pilot study towards the treatment of peritoneal carcinomatosis
por: Beck, Marcus, et al.
Publicado: (2015)

Intensification of Treatment for Angiosarcoma of the Breast with Accelerated Hyperfractionated Radiation, Hyperthermia, and Surgical Resection
por: Molitoris, Jason K, et al.
Publicado: (2017)

Neoadjuvant hyperfractionated accelerated radiotherapy plus concomitant 5-fluorouracil infusion in locally advanced rectal cancer: A phase II study
por: Gural, Zeynep, et al.
Publicado: (2018)

Dose-volumetric parameters and prediction of severe acute esophagitis in patients with locally-advanced non small-cell lung cancer treated with neoadjuvant concurrent hyperfractionated-accelerated chemoradiotherapy
por: Manapov, Farkhad, et al.
Publicado: (2013)

Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma—A Critical Review
por: Komotar, Ricardo J., et al.
Publicado: (2008)

Apatinib Plus Temozolomide for Recurrent Glioblastoma: An Uncontrolled, Open-Label Study
por: Wang, Yong, et al.
Publicado: (2019)

A non-randomised, single-centre comparison of induction chemotherapy followed by radiochemotherapy versus concomitant chemotherapy with hyperfractionated radiotherapy in inoperable head and neck carcinomas
por: Graf, Reinhold, et al.
Publicado: (2006)

Hyperfractionated abdominal reirradiation for gastrointestinal malignancies
por: Hunt, Andrew, et al.
Publicado: (2018)

Trotabresib (CC-90010) in combination with adjuvant temozolomide or concomitant temozolomide plus radiotherapy in patients with newly diagnosed glioblastoma
por: Vieito, Maria, et al.
Publicado: (2022)

Accelerated or hyperfractionated radiotherapy for esophageal carcinoma: a meta-analysis of randomized controlled trials
por: Liu, Yingyu, et al.
Publicado: (2017)

Patient-Specific Planning for Thermal Magnetic Resonance of Glioblastoma Multiforme
por: Oberacker, Eva, et al.
Publicado: (2021)

PET measured hypoxia and MRI parameters in re-irradiated head and neck squamous cell carcinomas: findings of a prospective pilot study
por: Rogasch, Julian, et al.
Publicado: (2021)

Regional hyperthermia and moderately dose-escalated salvage radiotherapy for recurrent prostate cancer. Protocol of a phase II trial
por: Müller, Arndt-Christian, et al.
Publicado: (2015)

Survival benefits of hypofractionated radiotherapy combined with temozolomide or temozolomide plus bevacizumab in elderly patients with glioblastoma aged ≥ 75 years
por: Ohno, Makoto, et al.
Publicado: (2019)

Radiotherapy plus Concomitant Adjuvant Temozolomide for Glioblastoma: Japanese Mono-Institutional Results
por: Oike, Takahiro, et al.
Publicado: (2013)

Radiotherapy Plus Concurrent or Sequential Temozolomide for Glioblastoma in the Elderly: A Meta-Analysis
por: Yin, An-an, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_dscoq7oja9bjroa956kvo6geo8